Videos
Watch the latest videos from IHME, including data stories, events, seminars, and training tutorials.
Q&A: Global burden of headache disorders
Headache disorders, especially migraine and tension-type headache, are among the most common and disabling conditions worldwide
Roux Prize 2025 Recipient: Dr. Adekemi Adeniyan
Dr. Adekemi Adeniyan, Executive Director of the Dentalcare Foundation, rural dentist, and advocate for oral health advancement in Nigeria, has been named IHME’s 2025 Roux Prize winner.
Launch of the Global Burden of Disease Study 2023
This session launched the GBD 2023 results and their discussion in The Lancet, providing a foundation for evidence-based dialogue on health challenges and opportunities.
GBD 2023: Leading causes of death around the world
Causes of death are shifting from infectious to non-communicable diseases, creating new global health challenges, particularly for low-income countries
GBD 2023: The global burden of diseases, injuries, and risk factors
Almost half of the global mortality and morbidity in 2023 was attributable to 88 modifiable risk factors
GBD 2023: New findings on global mortality and life expectancy
Despite population growth and aging, the 2023 global age-standardized mortality rate declined 67% since 1950
Q&A: Global burden of cancer and forecasts to 2025
Cancer was estimated to be the second-leading cause of death globally in 2023 with cancer deaths expected to rise to over 18 million in 2050, according to new research published in The Lancet.
Q&A: Cardiovascular diseases caused 1 in 3 global deaths in 2023
Learn more from lead author, Dr. Greg Roth.
Q&A: The impact of low bone mineral density
Low bone mineral density (BMD) is not one of the well-known risk factors to health, but it has a particular effect on bones—weaker and more vulnerable to fracture.
Q&A: Nearly half of people with diabetes don't realize they have the disease
Lauryn Stafford, first author and researcher at IHME, presents findings from a new study that analyzed the diabetes care cascade
Q&A: HIV-related mortality among children and adolescents on antiretroviral therapy
A new analysis examined HIV-related mortality among children and adolescents (aged 0 to 14 years) who have received antiretroviral therapy (ART).
Q&A: Which US counties deliver the best—and worst—health care?
New research from IHME evaluates health care systems across 3,110 US counties to understand which are performing the best and which are not.
The CommonHealth Live! on Financing Global Health in 2025
Dr. Chris Murray speaks with Stephanie Psaki, Global Health Policy Center Senior Adviser at the Center for Strategic and International Studies (CSIS) about the findings from IHME's Financing Global Health 2025 report.
Q&A: Global prevalence of kidney failure with replacement therapy
This new study published in The Lancet Global Health provides the first global, regional, and national estimates of kidney failure with replacement therapy (KFRT)
Financing Global Health 2025, Q&A with Dr. Angela Apeagyei
Lead author Dr. Angela Apeagyei, Assistant Professor at IHME, presents FGH 2025 findings in this Q&A video.